Clinical data | |
---|---|
Pronunciation | /droʊˈpɛrIdɔːl/ |
Pregnancy category |
|
Routes of administration | Intravenous, Intramuscular |
Drug class | Typical antipsychotic |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Metabolism | Hepatic |
Elimination half-life | 2.3 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.008.144 |
Chemical and physical data | |
Formula | C22H22FN3O2 |
Molar mass | 379.435 g·mol−1 |
3D model (JSmol) | |
| |
|
Droperidol /droʊˈpɛrɪdɔːl/ (Inapsine, Droleptan, Dridol, Xomolix, Innovar [combination with fentanyl]) is an antidopaminergic drug used as an antiemetic (that is, to prevent or treat nausea) and as an antipsychotic. Droperidol is also often used as a rapid sedative in intensive-care treatment, and where "agitation aggression or violent behavior"[4] are present.[5][6]